Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is headquartered in Basking Ridge, New Jersey, and is focused on the developmentof oncology and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast cancer, gastric cancer, tenosynovial giant cell tumor, hypertension, dyslipidemia, diabetes, thrombosis,stroke risk reduction, acute coronary syndrome, and IV iron therapy.
Contact
Eitan Hagler
Injectofer Representative
E-mail: ehagler@dsi.com
Please click to visit our virtual booth »
